Retraction
Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway
Paper Information
Record ID:
31140
Author(s):
Journal:
Publication Date:
August 26, 2018
Retraction Date:
July 20, 2021
(4.3 years years ago)
Subjects:
Institution:
Department of Breast Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaCountry:
šØš³ ChinaArticle Type:
Publisher:
Wiley
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (35)
35
Total Citations16
Post-Retraction(45.7%)
19
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
2
Within 30 days
10
Within 1 year
1
After 2+ years
986
Days since retraction (latest)
Research Progress of Long Non-Coding RNA in Tumor Drug Resistance: A New Paradigm
Jing Zhang, Le Wu, Chenchen Wang et al. (5 authors)
Drug Design Development and Therapy
Open Access
Published: Apr 2024
9 citations
9 citations
986 days after retraction
Landscape of NcRNAs involved in drug resistance of breast cancer
Yujuan Kang
Clinical & Translational Oncology
Open Access
Published: Apr 2023
10 citations
10 citations
636 days after retraction
Plumbagin Enhances the Anticancer Effects of PF Chemotherapy via Downregulation of the PI3K/AKT/mTOR/p70S6K Pathway in Human Tongue Squamous Cell Carcinoma
Shuting Pan, Fangfei Ye, Gan Huang et al. (4 authors)
Journal of Oncology
Open Access
Published: Feb 2023
5 citations
5 citations
573 days after retraction
The Prognostic Value and Biological Functions of <i>HFM1</i> in Breast Cancer
Yingxia Ying, Yiling Meng, Lei Bian et al. (10 authors)
Epigenomics
Published: Feb 2023
1 citation
1 citation
561 days after retraction
LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity
Kelin She, Shushuai He, Xiao Lu et al. (7 authors)
Journal of Thoracic Disease
Open Access
Published: Jan 2023
22 citations
22 citations
530 days after retraction
Advances in Endocrine Therapy for Breast Cancer
굩ē¶ å
Advances in Clinical Medicine
Published: Jan 2023
4 citations
4 citations
530 days after retraction
The Mechanisms of lncRNA-Mediated Multidrug Resistance and the Clinical Application Prospects of lncRNAs in Breast Cancer
Pingting Ye, Lei Feng, Shuo Shi et al. (4 authors)
Cancers
Open Access
Published: Apr 2022
36 citations
36 citations
277 days after retraction
Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer
YuanāShan Zhu, Jifeng Zhu
Advances in clinical chemistry
Published: Jan 2022
10 citations
10 citations
165 days after retraction
Estrogen receptorāpositive breast cancer survival prediction and analysis of resistanceārelated genes introduction
Shuai Chen, Fengyan Yuan, Yu Liu et al. (6 authors)
PeerJ
Open Access
Published: Oct 2021
11 citations
11 citations
98 days after retraction
Peer Review #2 of "Estrogen receptorāpositive breast cancer survival prediction and analysis of resistanceārelated genes introduction (v0.1)"
Shuai Chen, Fengyan Yuan, Yu Liu et al. (7 authors)
Unknown Journal
Open Access
Published: Oct 2021
98 days after retraction
Peer Review #1 of "Estrogen receptorāpositive breast cancer survival prediction and analysis of resistanceārelated genes introduction (v0.2)"
Shuai Chen, Fengyan Yuan, Yu Liu et al. (7 authors)
Unknown Journal
Open Access
Published: Oct 2021
98 days after retraction
Peer Review #3 of "Estrogen receptorāpositive breast cancer survival prediction and analysis of resistanceārelated genes introduction (v0.1)"
Dong Yin
Unknown Journal
Open Access
Published: Oct 2021
98 days after retraction
Peer Review #1 of "Estrogen receptorāpositive breast cancer survival prediction and analysis of resistanceārelated genes introduction (v0.1)"
Shuai Chen, Fengyan Yuan, Yu Liu et al. (7 authors)
Unknown Journal
Open Access
Published: Oct 2021
98 days after retraction
Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance
Min Xia, Xuyu Zu, Zuyao Chen et al. (5 authors)
Cancer Letters
Open Access
Published: Sep 2021
30 citations
30 citations
72 days after retraction
Vitamin D Affects the Warburg Effect and Stemness Maintenance of Non- Small-Cell Lung Cancer Cells by Regulating the PI3K/AKT/mTOR Signaling Pathway
SongYang Yiyan, Songyisha Yang, Dejia Li et al. (4 authors)
Current Cancer Drug Targets
Published: Jul 2021
13 citations
13 citations
10 days after retraction
Formononetin relieves the facilitating effect of lncRNA AFAP1-AS1-miR-195/miR-545 axis on progression and chemo-resistance of triple-negative breast cancer
Jingjing Wu, Wen Xu, Lina Ma et al. (12 authors)
Aging
Open Access
Published: Jul 2021
31 citations
31 citations
1 days after retraction
Utilizing the Hippo pathway as a therapeutic target for combating endocrine-resistant breast cancer
Jing Chen, Runlan Wan, Qinqin Li et al. (7 authors)
Cancer Cell International
Open Access
Published: Jun 2021
8 citations
8 citations
40 days before retraction
RNA Interference and Nanotechnology: A Promising Alliance for Next Generation Cancer Therapeutics
Guruprasadh Swaminathan, Aisha Shigna, Aviral Kumar et al. (6 authors)
Frontiers in Nanotechnology
Open Access
Published: Jun 2021
32 citations
32 citations
41 days before retraction
LncRNA UCA1 elevates the resistance of human leukemia cells to daunorubicin by the PI3K/AKT pathway via sponging miR-613
Qiying Yao, Li Zhang, Yuchuan Wang et al. (6 authors)
Bioscience Reports
Open Access
Published: May 2021
12 citations
12 citations
71 days before retraction
Cyanidinā3ā<i>O</i>āglucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells
Li Xu, Jin Zhao, Tingcai Yan et al. (8 authors)
Journal of Food Science
Published: Apr 2021
28 citations
28 citations
83 days before retraction
Anti-tumour Effect of Cyanidin-3-o-glucoside Combined With Cisplatin in the Mice Xenograft Models of Cervical Cancer
Li Xu, Jingjing Mu, Xianjun Meng
Research Square (Research Square)
Open Access
Published: Mar 2021
1 citation
1 citation
127 days before retraction
An update on the role of long non-coding RNAs in the pathogenesis of breast cancer
Soudeh GhafouriāFard, Kasra Honarmand Tamizkar, Bashdar Mahmud Hussen et al. (4 authors)
Pathology - Research and Practice
Published: Feb 2021
18 citations
18 citations
161 days before retraction
The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
Haomeng Zhang, Jiao Wang, Yulong Yin et al. (5 authors)
Bioscience Reports
Open Access
Published: Jan 2021
34 citations
34 citations
187 days before retraction
Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein kinase B axis
Lili Ren, Huanhuan Zhou, Lei Lei et al. (6 authors)
Bioengineered
Open Access
Published: Jan 2021
13 citations
13 citations
200 days before retraction
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie, Man Chu, Gendi Song et al. (8 authors)
Seminars in Cancer Biology
Published: Nov 2020
96 citations
96 citations
247 days before retraction
The role of long noncoding RNA SNHG7 in human cancers (Review)
Zheng Bian, Wei Ji, Bing Xu et al. (7 authors)
Molecular and Clinical Oncology
Open Access
Published: Aug 2020
20 citations
20 citations
341 days before retraction
Long Noncoding RNA Regulator of Reprogramming Regulates Cell Growth, Metastasis, and Cisplatin Resistance in Gastric Cancer via miR-519d-3p/HMGA2 Axis
Wenhua Jin, Hua Zhang, Meng Li et al. (4 authors)
Cancer Biotherapy and Radiopharmaceuticals
Published: Jul 2020
11 citations
11 citations
383 days before retraction
Non-Coding RNAs as Regulators and Markers for Targeting of Breast Cancer and Cancer Stem Cells
Kirti S. Prabhu, Afsheen Raza, Thasni Karedath et al. (13 authors)
Cancers
Open Access
Published: Feb 2020
37 citations
37 citations
532 days before retraction
Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation
Mingjun Zheng, Yuexin Hu, Rui Gou et al. (7 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2020
52 citations
52 citations
540 days before retraction
Tenacissoside H Induces Apoptosis and Inhibits Migration of Colon Cancer Cells by Downregulating Expression of <i>GOLPH3</i> Gene
Zhongshi Hong, Haibin Zhuang, Chengzhi Qiu et al. (7 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Jan 2020
11 citations
11 citations
566 days before retraction
Long Non-Coding RNA in the Pathogenesis of Cancers
Yujing Chi, Di Wang, Junpei Wang et al. (5 authors)
Cells
Open Access
Published: Sep 2019
723 citations
723 citations
688 days before retraction
NEMP1 Promotes Tamoxifen Resistance in Breast Cancer Cells
Yanyan Liu, Chuang Tong, Jun Cao et al. (4 authors)
Biochemical Genetics
Published: May 2019
12 citations
12 citations
801 days before retraction
A comprehensive overview of oncogenic pathways in human cancer
Feng Li, Tan Wu, Yanjun Xu et al. (14 authors)
Briefings in Bioinformatics
Published: Apr 2019
46 citations
46 citations
834 days before retraction
Long non-coding RNAs: Functional regulatory players in breast cancer
R.A. Youness, Mohamed Z. Gad
Non-coding RNA Research
Open Access
Published: Feb 2019
97 citations
97 citations
896 days before retraction
Daphnoretin: An invasion inhibitor and apoptosis accelerator for colon cancer cells by regulating the Akt signal pathway
Suyang Yu, Hong Guo, Xin Gao et al. (5 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2019
18 citations
18 citations
922 days before retraction
Quick Stats
Total Citations:
35
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025